(Q40587499)

21 September 2017

1 reference

title

Comparative tolerability profiles of oral antidiabetic agents (English)

1 reference

21 September 2017

2

1 reference

21 September 2017

A J Krentz

1

1 reference

PubMed ID

7848543

21 September 2017

C J Bailey

series ordinal

3

1 reference

21 September 2017

1 October 1994

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

223-241

1 reference

21 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199411040-00002

21 September 2017

0 references

cites work

Safety Profile of Acarbose, an α-Glucosidase Inhibitor

1 reference

12 December 2020

Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study

1 reference

12 December 2020

Type 2 (non-insulin-dependent) diabetes--an epidemiological overview

1 reference

12 December 2020

Diabetic macrovascular disease and serum lipids: is there a connection?

1 reference

12 December 2020

Drugs inducing hypoglycemia.

1 reference

12 December 2020

Metformin: a review of its pharmacological properties and therapeutic use

1 reference

12 December 2020

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

1 reference

12 December 2020

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

1 reference

12 December 2020

Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush

1 reference

12 December 2020

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

12 December 2020

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

1 reference

12 December 2020

Severe Hypoglycaemia During Treatment with Glipizide

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Metformin and glibenclamide: comparative risks

1 reference

12 December 2020

Epidemiology of adverse drug reactions to phenformin and metformin

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

Lactate homeostasis and lactic acidosis

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Biguanide-associated lactic acidosis. Case report and review of the literature

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work?

1 reference

12 December 2020

Hypoglycaemic, Antihyperglycaemic and Antidiabetic Drugs

1 reference

12 December 2020

Malabsorption of Vitamin B12 in Diabetic Patients Treated with Phenformin: A Comparison with Metformin

1 reference

12 December 2020

Oral hypoglycaemics for diabetes: when and which?

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

The genetic control of phenformin 4-hydroxylation

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced hypoglycemia. A review of 1418 cases.

1 reference

12 December 2020

Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study

1 reference

12 December 2020

Chlorpropamide-induced hyponatremia: incidence and risk factors

1 reference

12 December 2020

Recovery from metformin overdose

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Sulphonylureas in the treatment of non-insulin-dependent diabetes

1 reference

12 December 2020

Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy

1 reference

12 December 2020

1 reference

12 December 2020

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

12 December 2020

Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes

1 reference

12 December 2020

Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.

1 reference

12 December 2020

The influence of Guar gum on absorption of metformin from the gut in healthy volunteers

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Acarbose for non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Leucocytoclastic vasculitis and pneumonitis induced by metformin

1 reference

12 December 2020

1 reference

12 December 2020

Lactic acidosis in severe asthma

1 reference

12 December 2020

Undesired effects of the sulphonylurea drugs.

1 reference

12 December 2020

The status of metformin in Canada

1 reference

12 December 2020

Sulphonylureas in the treatment of non-insulin-dependent diabetes

1 reference

12 December 2020

Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Reduction of metformin renal tubular secretion by cimetidine in man

1 reference

12 December 2020

Insulin and atheroma. 20-yr perspective

1 reference

12 December 2020

Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet

1 reference

12 December 2020

Lawrence Lecture. Hypoglycaemia and diabetes

1 reference

12 December 2020

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics.

1 reference

12 December 2020

Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Leg Blood Flow and Muscle Metabolism in Occlusive Arterial Disease of the Leg before and after Reconstructive Surgery

1 reference

12 December 2020

The natural history of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Scope and specificity of acarbose in slowing carbohydrate absorption in man

1 reference

12 December 2020

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

12 December 2020

Metformin and the sulphonylureas: the comparative risk

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Diarrhea and Metformin in a Diabetic Clinic

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Metformin revisited: its actions and indications for use.

1 reference

12 December 2020

Lactic acidosis in biguanide-treated diabetics: a review of 330 cases

1 reference

12 December 2020

Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide

1 reference

12 December 2020

Treatment of type II diabetes

1 reference

12 December 2020

Influence of oxidation polymorphism on phenformin kinetics and dynamics

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

Tolbutamide-induced hemolytic anemia

1 reference

12 December 2020

The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes.

1 reference

12 December 2020

Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide

1 reference

12 December 2020

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics

1 reference

12 December 2020

Biguanides and sulfonylureas as combination therapy in NIDDM.

1 reference

12 December 2020

Hyperglycaemia and absorption of sulphonylurea drugs

1 reference

12 December 2020

A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group

1 reference

12 December 2020

10.2165/00002018-199411040-00002

Identifiers

DOI

1 reference

PubMed ID

7848543

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7848543